Le Revenu D'Intérêts Changement Date
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Arrowhead Research USD 16.93M 66K 2026-06
Astellas Pharma JPY 4.12B 2.94B 2024-03
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Celltrion KRW 779M 157.66M 2026-03
Exelixis USD 14.21M 1.92M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Kangmei Pharma CNY 2.44M 635.78K 2026-03
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Medical Developments International AUD 174K 31K 2024-12
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
OPKO Health USD 3.01M 16K 2026-03
Pfizer USD -0.04 115M 2026-06
Pharma Mar EUR 1.63M 3.17M 2025-12
Qiagen NV USD 10.56M 9.44M 2026-03
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Sartorius EUR 14.8M 5.3M 2026-06
Tilray USD 12.83M 20.19M 2024-05
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06
Zealand Pharma A/S 74M 28.41M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M 2026-03